Vermiscab-A Oral Suspension
By Vermiscab-A
Rx
10ml Oral Suspension in a Bottle

Composition
Ivermectin(3mg) + Albendazole(400mg)

Manufacturer - Sigman Wellness
202 & 207, sundaram arcade, opp. shukan mall, sciences city road, ahmedabad gujarat 380060 india

Expires on or after
July, 2026

liver
When using Vermiscab-A Oral Suspension, it is important to be cautious if you have liver disease. In such cases, your doctor may need to adjust the dose of the medication. It is advisable to inform your doctor if you experience symptoms of jaundice, such as yellowing of the eyes and skin, itching, or clay-colored stools while using this medicine. Your doctor will be able to provide guidance specific to your liver condition and ensure your safety during treatment with Vermiscab-A Oral Suspension.

kidney
Vermiscab-A Oral Suspension is likely safe for use in patients with kidney disease. Data indicates dose adjustment may not be required. Consult your doctor for guidance.

alcohol
When consuming alcohol with Vermiscab-A Oral Suspension, there is a risk of experiencing excessive drowsiness. It is important to be cautious with alcohol intake while using this medication.

driving
When using Vermiscab-A Oral Suspension, be cautious about driving as it may reduce alertness, cause vision issues, or lead to drowsiness and dizziness. Avoid driving if you experience these symptoms.

pregnancy
Vermiscab-A Oral Suspension may not be safe to use during pregnancy. Limited human studies are available, but animal studies suggest potential harm to the developing baby. Your doctor will consider the risks and benefits before prescribing this medicine to you. Please consult your doctor.

breastfeeding
Vermiscab-A Oral Suspension appears safe for breastfeeding; minimal data indicates low risk to the baby.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | ANTI INFECTIVES |
| Action Class | - |
₹25
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 11-Feb-2025
